News
 

A new analysis of the SPARCL trial has shown that in patients with recent stroke or transient ischemic attack (TIA), the total number of vascular events prevented with atorvastatin was more than twice the number of first events prevented.

Since the Centers for Disease Control and Prevention (CDC) confirmed the first US case of novel coronavirus infection on January 20, much of the clinical focus has naturally centered on the virus' prodromal symptoms and severe respiratory effects.

Variations in the composition of the microbiota are associated with different multiple sclerosis (MS) phenotypes, according to a new study published in Annals of Clinical and Translational Neurology. the findings demonstrate the importance of patient stratification in studies of the microbiota in MS and also identify potential therapeutic targets...

In a review of Current Opinion In Neurology they illustrate the frequency and trends of the comorbidity of epilepsy and dementia and the effects of antiepileptic drugs (AEDs) on cognitive functions.

Is breastfeeding associated with reduction in postpartum relapses in women with multiple sclerosis?

Individuals with radiologically isolated syndrome (RIS) have incidental magnetic resonance imaging (MRI) abnormalities suggestive of multiple sclerosis (MS).

A second phase 3 study of the investigational drug MD1003 (MedDay Pharmaceuticals), a highly concentrated pharmaceutical-grade biotin being studied for multiple sclerosis (MS), did not meet its primary and secondary endpoints, the company announced.

In amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), spinal and lower brainstem motor neurons degenerate, but some motor neuron subtypes are spared, including oculomotor neurons (OMNs). The mechanisms responsible for this selective degeneration are largely unknown, but the molecular signatures of resistant and vulnerable motor...

Smartphone use in patients with primary headache is connected to more medication use and less pain relief, new research shows.

The incidence rate of many cardiovascular events is more than doubled in patients with multiple sclerosis (MS), compared with matched controls without MS, new research shows.